Latest National Heart, Lung, and Blood Institute Stories
New research supports the findings of a landmark drug comparison study published in 2002 in which a diuretic drug or â€œwater pillâ€ outperformed other medications for high blood pressure. A scientific team including investigators from The University of Texas Health Science Center at Houston reports the findings in the May 11 issue of the Archives of Internal Medicine.
An international research team has identified a number of unsuspected genetic variants associated with systolic blood pressure (SBP), diastolic blood pressure (DBP), and hypertension (high blood pressure), suggesting potential avenues of investigation for the prevention or treatment of hypertension.
WASHINGTON, April 23 /PRNewswire/ -- The Washington, D.C.
Scientists have discovered a link between two genetic variants and an increased risk of ischemic stroke.
A type of surgery which reshapes the scarred left ventricle, the main pumping chamber of the heart, and is often done in conjunction with heart bypass, not only failed to reduce deaths and hospitalizations in heart failure patients but also did not improve patients' quality of life compared to bypass alone after four years of follow-up, according to the results of a large international clinical trial funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of...
New results from the Womenâ€™s Health Initiative (WHI) Observational Study provide additional evidence that aspirin may reduce the risk of death in postmenopausal women who have heart disease or who have had a stroke.
Biosamples from the Framingham Heart Study will be used to Discover New Blood Tests for Heart Disease WALTHAM, Mass., March 12 /PRNewswire/ -- BG Medicine, a biotechnology company focused on the discovery and development of novel diagnostic biomarkers, today announced the signing of a Cooperative Research and Development Agreement (CRADA) with the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health and Boston University (BU). Under the agreement, the three...
Make every Monday 'Wear Red' Day NEW YORK, Feb. 5 /PRNewswire-USNewswire/ -- Tomorrow, millions of Americans will wear red to highlight women's risk of dying from heart disease.
Event to Benefit The Larry King Cardiac Foundation NEW YORK, Feb.
Researchers at the University of California, Davis have discovered that a prototype drug reduces heart enlargement, one of the most common causes of heart failure.